Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Iridex Receives Big Orders for Ophthalmic Laser Systems

Photonics.com
May 2013
MOUNTAIN VIEW, Calif., May 1, 2013 — Iridex Corp. announced Tuesday that it has received two large orders from developing countries for proprietary ophthalmic laser-based medical systems.

The orders, totaling more than $500,000, demonstrate the growth of the ophthalmology market in the "BRIC" (Brazil, Russia, India and China) economies and have begun causing a paradigm shift in the US and European markets based on the advances of laser-based therapy treatments, said President and CEO Will Moore.

“We believe that the growth in the market for lasers is being driven in large part by the rapid spread of diabetes and diabetes-related eye diseases in developing countries as well as the practicality of new laser treatments,” Moore said.

The health systems in many developing countries are not equipped to support current drug treatments for diabetes-related eye diseases such as diabetic macular edema (DME), he said. Typical treatment includes a regular series of drug injections in the eye, which are costly and impractical in remote areas.

Iridex’s lasers are “as effective as drugs in terms of outcomes, are much less costly to a healthcare system, and are much easier to administer from a logistics standpoint because they provide durable results,” Moore said.

For more information, visit: www.iridex.com


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.